Drug interactions between warfarin and lenvatinib in a patient with the CYP2C9*1/*3 and VKORC1-1639G/A genotype.
Hironobu YagishitaShinichiro MinamiYumiko AkamineShotaro KatoKatsunori IijimaMasatomo MiuraPublished in: Journal of clinical pharmacy and therapeutics (2019)
Lenvatinib-dependent (S)-warfarin inhibition could involve CYP2C9 and CYP2C8. After initiating warfarin plus lenvatinib, INR assays are necessary.